跳至主要内容
临床试验/NCT01638689
NCT01638689已完成1 期

A PET Study to Determine Alterations in Serotonin Levels in Human Brain After a Single Dose of Escitalopram

Karolinska Institutet2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年9月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
2
主要终点
Change in binding potential of 11C-AZ10419369 between baseline and post-dose condition

研究概览

简要总结

Healthy males were examined with positron emission tomography (PET) and the radioligand 11C-AZ10419369, before and after administration of a single dose escitalopram. A change in the binding potential of 11C-AZ10419369 between the baseline and the post-dose condition was hypothesized to reflect a change in serotonin concentration.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
20 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Signed informed consent
  • Male gender
  • Age 20 to 30 years
  • Healthy according to physical examination, ECG, MRI and blood chemistry

排除标准

  • Past or present psychiatric disease
  • Past or present brain disorder or injury, including loss of consciousness for more than five minutes
  • Past or present drug or alcohol abuse
  • Past or present use of antidepressant or antipsychotic medications
  • Regular use of medications (including herbals), that could interfere with the pharmacodynamics or pharmacokinetics of escitalopram
  • Significant abnormality on ECG
  • Structural abnormality in the brain confirmed by MR examination
  • Claustrophobia
  • Any metal devises or implants in the body
  • Intolerance to escitalopram or any of the components of the formula
  • Predisposition to motion sickness
  • Inability to understand and comply with the study requirements
  • Any medical condition that, in the opinion of the investigator, make the subject unsuitable for the study or put the subject at additional risk

结局指标

主要结局

Change in binding potential of 11C-AZ10419369 between baseline and post-dose condition

时间窗: One day (PET measurement before and after escitalopram administration on the same day)

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Magdalena Nord

MD

Karolinska Institutet

研究点 (2)

Loading locations...

相似试验

A PET Study to Determine Alterations in Serotonin... | 临床试验